Case Study
Monday, October 06
11:00 AM - 11:25 AM
Live in Berlin
Less Details
2025 is the year the long-anticipated EU HTA Regulation has come into application, and this year the first products will benefit from Joint Scientific Consultations and be subject to Joint Clinical Assessments. What do these new procedures mean for your company? How do you prepare for the tight timelines and milestones of JCA? In this session participants will get further insights into the new procedures, and receive practical advice for navigating them.
In this presentation you will learn:
Political scientist with advocacy and project management experience.